SRRK in “GLP-1 Eats Everything”
Scholar Rock Holding Corporation
Scholar Rock is developing muscle-preservation therapies intended to complement GLP-1 weight loss and address loss of lean mass.
SRRK impact map — “GLP-1 Eats Everything”
How this story travels from the headline to SRRK’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading SRRK impact map…
Price history, marked with story events
May 26, 2026 – Aug 26, 2026 · 65 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
GLP-1 Eats Everything
Appetite suppression as a macro variable.
BULL side — Scholar Rock is developing muscle-preservation therapies intended to complement GLP-1 weight loss and address loss of lean mass.
Read the full GLP-1 Eats Everything story